<DOC>
	<DOCNO>NCT00375011</DOCNO>
	<brief_summary>The three objective trial : 1 . To demonstrate decline hepatic metabolic function measure BreathID correlate change CTP MELD score patient cirrhosis . 2 . To determine critical value hepatic metabolic function measure BreathID predict patient risk develop complication cirrhosis . 3 . To determine critical value hepatic metabolic function measure BreathID predict patient risk liver relate mortality . The hypothesis BreathID breath test correlate CTP MELD score , threshold establish help predict risk complication cirrhosis mortality .</brief_summary>
	<brief_title>Breath Test Assess Hepatic Metabolic Reserve Predict Hepatic Decompensation Cirrhotics</brief_title>
	<detailed_description>BACKGROUND : 1 . Mortality patient chronic liver disease cirrhosis : Chronic liver disease 9th common cause death United States . Unfortunately , mortality secondary chronic liver disease , cirrhosis complication expect increase future . This primarily due maturation Hepatitis C Virus ( HCV ) epidemic , rise rate hepatocellular carcinoma ( HCC ) increase prevalence non-alcoholic steatohepatitis ( NASH ) . Mortality patient chronic liver disease typically confine patient cirrhosis ; mortality risk patient long assessed Child-Pugh-Turcotte ( CTP ) score . More recently , Model End-Stage Liver Disease ( MELD ) show accurately predict 30 day survival patient cirrhosis . The MELD score utilize United Network Organ Sharing ( UNOS ) prioritize patient await liver transplantation . In general , decline liver function increase CTP and/or MELD score precipitate complication cirrhosis ; gastrointestinal bleeding portal hypertension ( variceal non-variceal ) , ascites , spontaneous bacterial peritonitis ( SBP ) , hepatic encephalopathy ( NE ) , hepato-renal syndrome ( type 1 2 ) HCC . Patients consider stable cirrhosis intact hepatic function prior complication cirrhosis . Such patient CTP score less 7 ; reflective Childs class A cirrhosis . Approximately 3-5 % patient stable Child class A cirrhosis develop worsen hepatic function and/or complication cirrhosis decompensate yearly basis . In many patient development complication , deterioration global liver function rise MELD slow gradual process allow sufficient time successful transplantation . In contrast , approximately one-third patient cirrhosis develop rapid hepatic decompensation precipitous rise MELD die complication cirrhosis either consider receive liver transplant . This observation explain pre-transplant mortality patient UNOS wait list actually great patient low MELD , high MELD score . It currently believe patient marginal hepatic metabolic capacity hepatic reserve place risk develop complication cirrhosis rapid deterioration complication occur . 2 . Identifying patient marginal hepatic reserve risk complication decompensation : Tests assess hepatic metabolic function conduct administer either intravenously orally compound high hepatic extraction ratio and/or rapid hepatic metabolism . The rate parent compound remove serum metabolic product parent compound appear either blood , urine , breath saliva reflect hepatic metabolic function . Some compound successfully utilized purpose include choline , caffeine , galactose , aminopyrine , erythromycin , lidocaine methionine Methacetin [ N- ( 4-Methoxy-phenyl ) acetamide ] . Previous study utilize battery liver function test demonstrate test correlate worsen fibrosis cirrhosis . The hepatic metabolism lidocaine monoethylglycinexylidide ( MEGX ) show decline increase liver fibrosis worsen stage cirrhosis , improve successful treatment underlie liver disease , accurately predict patient stable cirrhosis await liver transplantation risk develop future hepatic decompensation . Unfortunately , administer lidocaine perform test associate parasthesias could precipitate cardiac arrythmias . Thus , promise potential liver function test use lidocaine purpose largely abandon . 3 . BreathID : Breath test 13C labeled substrate provide safe , non-invasive mean measure hepatic metabolism . 13C stable , non-radioactive isotope incorporate specific location within test substrate would release compound metabolize liver . 13C-compounds utilized purpose administer orally , rapidly absorb , metabolize liver 13C measure exhale breath within 20-30 minute . Hepatic metabolism compound assess measure ratio 13C/12C exhale breath . The ability detect , differentiate quantify 13C 12C exhale CO2 greatly facilitate recent development BreathIDÂ® collection system analyzer unit . This portable device continuously sense exhaled breath 13CO2 real-time nasal cannula worn patient . The Breath ID devise utilize 13C-urea substrate currently approve Food Drug Administration test presence H. Pylori infection . The 13C label substrate utilized Breath ID device ass liver function methacetin . Preliminary data demonstrate metabolism 13C-methacetin decline increase hepatic fibrosis patient chronic HCV parallel clinical course patient acute liver failure prior liver transplantation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1 . Cirrhosis determine liver histology clinical finding . 2 . Age &gt; 18 year 1 . Known suspect HCC 2 . Hepatopulmonary syndrome 3 . Hepatorenal syndrome ( creatinine &gt; 2.5 mg/dl ) 4 . Refractory ascites ( More 1 paracentesis within precede 3 month enrollment . A single paracentesis perform diagnostic purpose exclusion ) 5 . Hyponatremia 6 . Prior TIPS placement 7 . Prior episode variceal hemorrhage 8 . MELD score &gt; 25 9 . Any patient whose expected time liver transplantation le 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>MELD-Model End Stage Liver Disease score</keyword>
	<keyword>CTP-Child-Turcotte-Pugh score</keyword>
	<keyword>MEGX-monoethylglycinexylidide-resultant metabolism lidocaine</keyword>
	<keyword>HCC-Hepatocellular carcinoma</keyword>
	<keyword>HCV-Hepatitis C virus</keyword>
	<keyword>NASH-Non-alcoholic Steatohepatitis</keyword>
</DOC>